• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
BlackDoctor.org
Where Wellness & Culture Connect

Where Wellness & Culture Connect

  • Health Conditions
  • Wellness
  • Lifestyle
  • Longevity
  • Resource Centers
    • Cancer Resource Center
    • Covid Resource Center
  • Find A Doctor
  • BDO TV
Home / Health Conditions / Covid-19 Vaccine Rollout / FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk

FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk

moderna booster shot

Mirroring a similar recommendation issued last month for the Pfizer COVID-19 vaccine, an expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.

Panelists recommended that everyone aged 65 or older who received the two-dose Moderna regimen get a third dose, as well as any younger adult who might be at high risk for COVID-19 due to a medical condition or a job that increases their exposure to SARS-CoV-2, The New York Times reports.

RELATED: ‘Mix and Match’? Study Supports Following J&J Vaccine With Pfizer, Moderna

What the data shows

The data presented was not particularly decisive, committee members say, but they note that a precedent had been set in September when the FDA gave emergency authorization to booster shots for the millions of Americans who’d gotten the Pfizer-BioNTech vaccine.

You May Also Like
5 Top Sunscreens for Black Skin

The evidence of a need for booster shots was clearer for the Pfizer vaccine, however.

In data presented to the panelists last month, one study from the U.S. Centers for Disease Control and Prevention found that four months after a person’s second dose of the Pfizer vaccine, its effectiveness in preventing illness requiring hospitalization fell from 91% to 77%.

But with the Moderna vaccine, the drop-off over time was much less dramatic, making the justification for any booster shot much weaker.

Acknowledging that, Moderna argued instead that a booster could still be useful in preventing mild or moderate forms of COVID-19.

You May Also Like
15 Natural Remedies for Aches and Pains

As part of the data presented, Moderna says its study found that

Continue Reading

The Latest In Covid-19 Vaccine Rollout

Novavax vaccine

How Does the Novavax COVID Vaccine Differ From the mRNA Options?

For a year and a half Americans looking to get a COVID-19 vaccine have had the same three options to choose from. However, if you are planning to get vaccinated in the near future, you now have another option to read more about How Does the Novavax COVID Vaccine Differ From the mRNA Options?
Pfizer

Pfizer Asks FDA to Approve Its Vaccine for Children Under 5

Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to authorize its two-dose COVID vaccine for emergency use in children under 5 while it continues to research the power of a third shot in these read more about Pfizer Asks FDA to Approve Its Vaccine for Children Under 5
Moderna

FDA Gives Moderna COVID Vaccine Full Approval

Moderna's COVID-19 vaccine has received full approval for use in people 18 and older, the U.S. Food and Drug Administration announced Monday. The vaccine, which has been available for that age group under emergency use authorization (EUA), will be marketed read more about FDA Gives Moderna COVID Vaccine Full Approval
booster shot

FDA Approves Pfizer Booster Shots for Kids Aged 12-15

The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer's booster shot against COVID-19 for youths aged 12 to 15. The move comes as the Omicron variant spreads across the country and students return to classrooms read more about FDA Approves Pfizer Booster Shots for Kids Aged 12-15
Pfizer

FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday

Younger adolescents may soon be eligible for COVID-19 booster vaccines, possibly by early next week. The U.S. Food and Drug Administration is planning on Monday to broaden booster eligibility to include 12- to 15-year-olds, sources told the New York Times. This read more about FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
Pfizer booster shot

FDA Approves Pfizer Boosters for Those Aged 16-17

The U.S. Food and Drug Administration on Thursday approved the emergency use of the Pfizer coronavirus booster shot for Americans aged 16 and 17. The move comes as the Delta variant is fueling surges in infections and hospitalizations in some read more about FDA Approves Pfizer Boosters for Those Aged 16-17

Primary Sidebar

Subscribe to our newsletter

Poll

Popular Posts

  • Football Legend & Coach Deion Sanders Has Toes AmputatedFootball Legend & Coach Deion Sanders Has Toes Amputated
  • Like Father, Like Son: ‘Miami Vice’ Star’s Son Handsome Like his DaddyLike Father, Like Son: 'Miami Vice' Star's Son Handsome Like his Daddy
  • LL Cool J & Wife Simone Smith Celebrate 25 Years Married: “We Celebrate Life”LL Cool J & Wife Simone Smith Celebrate 25 Years Married: "We Celebrate Life"
  • Marjorie Harvey: Fit, Fine & 57!Marjorie Harvey: Fit, Fine & 57!
  • 7 Ways To Prevent Yellow Eyes7 Ways To Prevent Yellow Eyes

Podcast

Footer

Where Wellness & Culture Connect

BDO is the world’s largest and most comprehensive online health resource specifically targeted to African Americans. BDO understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BDO gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

Connect With Us

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Learn More About

  • Hepatitis C
  • Diabetes
  • Sickle Cell
  • Mental Health
  • About Us
  • Privacy Policy
  • Advertise With Us
  • BlackDoctor.org Advertising and Sponsorship Policy
  • Daily Vitamina
  • TBH

Copyright © 2022, BlackDoctor, Inc. All rights reserved.